无锡途深智合人工智能科技有限公司及子公司上海途深生物科技有限责任公司（简称“途深智合”）近日宣布完成数百万元人民币的天使轮融资。本轮融资由诚美资本领投，资金将主要用于实验室的建设和团队搭建。
途深智合成立于2023年，是一家专注于人工智能蛋白质设计和制造的生物科技企业。该公司致力于为合成生物领域提供创新解决方案和新的产品开发。途深智合利用人工智能技术优化蛋白质设计，以期在生命科学研究和生物医药开发领域取得突破。
随着生物技术的不断进步和人工智能的应用日益广泛，途深智合的融资成功标志着投资者对于这一交叉领域的前景看好。途深智合的团队表示，他们将继续深化技术研发，推动人工智能在生物科技领域的应用，为人类健康事业贡献力量。
英文标题：DeepSeek Raises Angel Round for AI Protein Design
英文关键词：DeepSeek, AI Protein, Angel Round
英文新闻内容：
DeepSeek, a company specializing in AI-powered protein design and manufacturing, has announced the completion of a seven-figure RMB angel round. The funding, led by Chengmei Capital, will primarily be used for the construction of laboratories and team building.
Founded in 2023, DeepSeek is a biotechnology firm that leverages artificial intelligence to optimize protein design for the synthetic biology field. The company aims to provide innovative solutions and new product development in the life science research and biopharmaceutical sectors.
As biotechnology advances and AI applications become more widespread, DeepSeek’s successful funding round indicates investor confidence in the future of this interdisciplinary field. The team at DeepSeek plans to continue advancing their technological research and push the boundaries of AI applications in biotechnology, contributing to the advancement of human health.
【来源】https://36kr.com/p/2686282258132355
Views: 1